Pharmacokinetic and molecular docking studies to design antimalarial compounds targeting Actin I

OBJECTIVE: Malaria is an ancient disease that still causes more than 200 million of cases 7 with high mortality globally. Identification of new drug targets and development of novel antimalarial drugs with unique mode of action encounter the drug resistance and reduce the mortality by Plasmodium par...

Descripción completa

Detalles Bibliográficos
Autores principales: Guleria, Vandana, Pal, Tarun, Sharma, Bhanu, Chauhan, Shweta, Jaiswal, Varun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Qassim Uninversity 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589829/
https://www.ncbi.nlm.nih.gov/pubmed/34916893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589829/
https://www.ncbi.nlm.nih.gov/pubmed/34916893

Ejemplares similares